Gemini Pharmaceuticals Nigeria Limited was incorporated in 1972 by Bayer AG. Leverkusen and Dr. M.B Unuane with the objective of manufacturing and marketing Bayer AG’s pharmaceutical specialties in Nigeria. At inception, 60 % of its shares were owned by Bayer AG Leverkusen, West Germany and 40 % by Nigerians. In 1974, a Joint Venture Agreement was signed between Dr. M.B. Unuane, Dr.T.A. Odutola and Bayer AG, Leverkusen. The name of the Company was changed to Bayer Pharmaceuticals Nigeria Limited. The company then acquired 12 acres of land at Apapa/Oshodi Express Way, Amuwo Odofin, Lagos, for the purpose of erecting a pharmaceutical manufacturing company. The ultra-modern factory was commissioned in 1982. Commercial activities also commenced the same year.

In the late 1980s’ Bayer AG, as part of its global policy divested from its activities in the third world countries to allow indigenes to own and manage their subsidiary companies. The shares belong to Bayer AG and Dr. T.A Odutola was acquired by Dr. M.B. Unuane and the company was transferred to him on 30th June 1993 and reverts to its original name ‘Gemini Pharmaceuticals Nigeria Limited’, with a Franchise and License Agreement, to manufacture Bayer AG pharmaceutical specialties in Nigeria until 2002. Over the years, Gemini Pharmaceutical Nigeria Limited has distinguished itself as an indigenous company producing highly potent, world class ethical drugs. The company sustained its affiliation with Bayer AG. Leverkusen of Germany to produce some of its drugs, which has given it an edge over some local pharmaceutical companies in Nigeria.

The Gemini Factory was established with a clear mission: to strengthen Nigeria’s pharmaceutical manufacturing capacity and provide high-quality, affordable medicines for communities across the nation. What began as a modest production facility has steadily grown into a modern, well-equipped manufacturing hub driven by innovation, compliance, and a commitment to global standards.

From its early years, Gemini Factory invested in advanced technologies, skilled professionals, and internationally recognized production practices. These efforts positioned the factory as a trusted partner within Nigeria’s healthcare sector—capable of producing safe, effective, and reliable pharmaceutical products that meet the needs of a growing population.

Over the years, the factory expanded its operational capabilities, introduced new production lines, and strengthened quality assurance processes to align with global manufacturing benchmarks. This continuous growth reflects Gemini’s dedication to excellence and its vision to become a leading force in the region’s pharmaceutical industry.

Today, Gemini Factory stands as a symbol of progress, integrity, and innovation—a testament to years of strategic development, unwavering standards, and a passion for improving healthcare outcomes across Nigeria.